Article ID Journal Published Year Pages File Type
8750874 Respiratory Investigation 2016 5 Pages PDF
Abstract
A low starting dosage of afatinib might enable elderly or low PS patients with advanced refractory NSCLC to receive this drug as salvage therapy.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology and Microbiology (General)
Preview
Tolerability and efficacy of afatinib at a low starting dosage in 10 elderly or low performance status patients with advanced refractory non-small-cell lung cancer
Authors
, , , ,